NASDAQ NMS - GLOBAL MARKET · MENS
-7.33% · -$0.1250
Jyong Biotech Ltd

Jyong Biotech Ltd

Biotechnology
$1.58
+ Add to watchlist
Card

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is MENS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Jyong Biotech Ltd
Biotechnology
Founded
—
Listed
2025
Employees
27
HQ
TW

Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.

Company website →
Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$1.60
Day high
$1.71
Day low
$1.56
Previous close
$1.71
52W high
$1.71
-7.60% from high
52W low
$1.58
0% of range
Market cap
$126.6M
P/E
—
EPS
—
Dividend yield
—
Beta
—
Shares out
74.2M
Float
—
Volume
199.8K
Avg volume
—
VWAP
$1.62
Next earnings
—
Price history computed in-house
1W
-4.82%
1M
-4.82%
3M
-4.82%
1Y
-4.82%
YTD
-4.82%
SMA 50 $1.64 · below
SMA 200 $1.64 · below
52W position 0%
Veridion warehouse edge

Warehouse intelligence for MENS.

Veridion Score
33
0: —1: 482: 373: —4: —5: —
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
—
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

MENS insider activity

Jyong Biotech Ltd

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
$0
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: $0 across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for MENS.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

MENS contract awards, year to date.

Public federal awards linked to this ticker.

—
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MENS in this window.
Lobbying spend

MENS lobbying filings, year to date.

Registered lobbying filings matched to Jyong Biotech Ltd.

—
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MENS in this window.
Latest news · MENS
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for MENS.
Options
Sovereign unlock shows live options positioning for MENS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.